Cargando…
Targeting Triple Negative Breast Cancer Stem Cells by Heat Shock Protein 70 Inhibitors
SIMPLE SUMMARY: Triple negative breast cancer (TNBC) has been a leading cause of cancer deaths among women and limited treatment options are currently available. Consequently, developing the promising therapy for TNBC remains an unmet medical need. The aim of this study was to assess the effect of H...
Autores principales: | Tsai, Chia-Hung, Weng, Jing-Ru, Lin, Hsiang-Wen, Lu, Meng-Tien, Liu, Yu-Chi, Chu, Po-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562869/ https://www.ncbi.nlm.nih.gov/pubmed/36230821 http://dx.doi.org/10.3390/cancers14194898 |
Ejemplares similares
-
Heat Shock Protein 70 in Alzheimer's Disease
por: Lu, Rui-Chun, et al.
Publicado: (2014) -
Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma
por: Eugênio, Angela Isabel Pereira, et al.
Publicado: (2017) -
Simvastatin functions as a heat shock protein 90 inhibitor against triple‐negative breast cancer
por: Kou, Xinhui, et al.
Publicado: (2018) -
Heat shock protein 70 and anti–heat shock protein 70 antibodies in nasal secretions of patients with chronic rhinosinusitis
por: Tsybikov, Namjil N., et al.
Publicado: (2016) -
Heat Shock Protein 70 Inhibitors.
1. 2,5′-Thiodipyrimidine
and 5-(Phenylthio)pyrimidine Acrylamides as Irreversible Binders
to an Allosteric Site on Heat Shock Protein 70
por: Kang, Yanlong, et al.
Publicado: (2014)